RA Capital Nexus Fund II, L.P., Director, 10% Owner at Werewolf Therapeutics, Inc. (HOWL), bought 1,072,852 shares at $0.98 ($974K) on 2025-05-13, disclosed to the SEC on 2025-05-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.86 | 320,913 | $276K | 28.3% |
| 2 | $0.86 | 320,913 | $276K | 28.3% |
| 3 | $0.98 | 52,974 | $52K | 5.3% |
| 4 | $0.98 | 52,974 | $52K | 5.3% |
| 5 | $0.98 | 162,539 | $159K | 16.3% |
| 6 | $0.98 | 162,539 |
| $159K |
| 16.3% |
| Total | $0.91 avg | 1,072,852 | $974K | 100% |
| Filing → |
| JANX | BUY | 2023-07-21 | $12.3M | — | Filing → |
| DICE | BUY | 2023-03-30 | $29.6M | — | Filing → |
| ANTX | BUY | 2022-07-28 | $361K | — | Filing → |